PharmaReports: Neurodegenerative & Neuroelectrophysiological Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel focusses on the chronic neurodegenerative disorders. Reports investigating memory/cognitive decline are also listed here unless they are clearly unrelated to neurodegeneration. In addition, reports relating to acute neurodegeneration such as stroke and cerebral hemorrhage can be included here.
Showing results 51 - 97 of 97
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Coxibs - Past Problems and Future Potential
- Tysabri - Can Efficacy of VLA-4 Mechanism Overcome Safety Concerns?
- Commercial Insight: Parkinson's Disease - Increased Focus on Earlier Treatment and Managing Levodopa
- Commercial Perspectives: Multiple Sclerosis - How to Find Opportunities in an Unremitting Market
- Alzheimer's Disease - Diagnosis, Disease Modification and Prevention Key to Growing Market
- The Outlook for Niche CNS Disorders: Commercial opportunities in developing markets
- Commercial Opportunities from an Aging Population: Epidemiology, market and pipeline analysis across seven major indications
- Innovations in CNS: Novel therapeutics and future R&D strategies
- Gene Expression Profiling Markets
- UpdatesPlus-Nicotinic Receptors (January 2008)
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Pipeline Insight: Orphan Diseases in CNS - Amyotrophic Lateral Sclerosis
- Parkinson's Disease - Evidence of neuroprotection essential to progress treatment dynamics
- How to Conduct Clinical Trials in China
- Alzheimers Disease Market analysis and forecasts, 2007-2022
- Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics
- UpdatesPlus-Nicotinic Receptors (February 2008)
- Parkinson's Disease Market analysis and forecasts
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- Pipeline and Commercial Insight: Alzheimer's Disease
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- CNS Market Overview - neurology, pain and psychiatry
- Neuronal Nicotinic Receptors - April 2008
- Outsourcing in Drug Discovery
- Pipeline Insight: Acute Stroke: Commercial risk offsets high unmet need
- Neuronal Nicotinic Receptors - June 2008
- Monoclonal Antibodies Report: 2008 Update
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Neuronal Nicotinic Receptors - July 2008
- The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends)
- Therapeutic Monoclonal Antibodies Report 2008-2023
- Diagnostics in Neurology - Predictive biomarkers expand drug revenues
- Neuronal Nicotinic Receptors - August 2008
- Neuronal Nicotinic Receptors - September 2008
- The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Stakeholder Opinions: Vaccine adjuvants
- Ion Channel Trends 2008
- Kinase Screening & Profiling Trends 2008
- GPCR Screening & Profiling Trends 2008
- Neuronal Nicotinic Receptors - October 2008
- The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- The Future of RNAi Therapeutics: Drug Pipelines and Prospects
< Previous1 | 2
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development